These schedules indicate the recommended ages for routine administration of currently licensed childhood vaccines, as of December 1, 2007, for children aged 0 through 18 years.
Toxicity related to THC dose in pediatric edible cannabis ingestions
October 3rd 2023The degree of toxicity following pediatric ingestion of THC was correlated to the dose of THC, as ingestions of 1.7 mg/kg or more was predictive of severe and prolonged toxicity, according to a study published in Pediatrics.
FDA approves tocilizumab-bavi as biosimilar for PJIA, SJIA in children 2 years and up
October 2nd 2023Tocilizumab-bavi (Tofidence; Biogen) demonstrated a biosimilarity to tocilizumab (Actemra; Genentech) based on multifaceted clinical and non-clinical data for polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (sJIA) in children aged 2 years and up. This makes it the first tocilizumab biosimilar to be FDA-approved in the United States, according to Biogen.
2 Clarke Drive
Cranbury, NJ 08512